BioSpace News Archive

Phynd Technologies is pleased to announce that it has become a member of the College of Healthcare Information Management Executives Foundation.

BerGenBio ASA is pleased to announce it has been accepted for an oral presentation at the Society for Immunotherapy of Cancer’s 34th Annual Meeting, which is being held from 6-10 November 2019 in Maryland.

International medical imaging IT and cybersecurity company Sectra is extending its pre-operative orthopaedic planning solution for trauma cases with 3D templates from one of the largest orthopaedic companies, DePuy Synthes.

Medicare Shared Savings Program performance results released this week show Caravan Health accountable care organizations are leaders in savings and quality scores for another year.

On September 17th 2019 Karolinska University Hospital became the first hospital in the Nordic region to use laser ablation technique in the treatment of a patient with a brain tumor.

Kurin Inc., the inventor and manufacturer of 510-cleared and patented Kurin® blood culture collection sets, announced third quarter revenues increased 4.5 times over the revenue of the same period in 2018.

NanoString Technologies, Inc. announced the appointment of Mark Winham as senior vice president of Operations effective October 2, 2019.

ALX Oncology announced that it will be presenting clinical biomarker data from its ongoing ALX148 phase 1 clinical program at the SITC 34th Annual Meeting, November 6-10, 2019 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will be providing an overview of the Company’s clinical pipeline following recent updates on the AVP-786 partnered program in a presentation at the Cantor Healthcare Conference on Thursday, October 3, 2019 at 5:20 p.m. ET in New York, NY.

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the initiation of dosing in the RAISE study, its global, pivotal, Phase 3 clinical trial evaluating zilucoplan for the treatment of generalized myasthenia gravis (gMG)